Clinical Trials
3 trialsNCT02688803 2025-12-04
OTT15-04
Ottawa Hospital Research Institute
Phase 4 Terminated
NCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT01849380 2013-05-08
Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer
Shandong University
Phase 4 Unknown